Craig B. Thompson Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Craig B. Thompson is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 620 shares of REGN, which is worth approximately $428,023. The most recent transaction as insider was on Jan 02, 2025, when has been sold 166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 620
36.56% 3M change
36.56% 12M change
Total Value Held $428,023

Craig B. Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
166 Added 21.12%
620 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
135 Added 22.92%
454 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
40 Added 11.14%
319 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
-
279 Added 50.0%
279 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
Director
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
CBT

Craig B. Thompson

Director
Kenilworth, NJ

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN